Maze Cord Blood
Maze Cord Blood is a private US cord blood and tissue banking service that stores newborn stem cells for expectant-parent families. A subsidiary of Maze Health, it is no longer accepting new enrollments and now operates as a managed run-off, servicing its existing storage book.
- Company typePrivate
- Founded-
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Maze Cord Blood does
Maze Cord Blood Laboratories is a privately held, US-based cord blood and cord tissue banking service operating as part of the Maze Health group and headquartered in Westchester, New York. The company collects, processes, and cryogenically stores hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from umbilical cord tissue on behalf of expectant-parent families for potential future medical use in treating blood disorders, cancers, immune deficiencies, and regenerative medicine applications.
The company's core technical differentiator is the proprietary TissueQES processing method, which provides quantitative post-thaw evaluation of stem cell survival — a verification step most competitors do not perform. Operations are conducted under multiple industry accreditations (AABB, CAP, FACT, CLIA). The business runs on a subscription model: customers pay upfront processing fees at enrollment plus recurring annual storage fees for the duration of custody, typically aligned to a 20-year horizon from the child's birth date. Distribution is direct-to-consumer via phone-based enrollment and the company website.
As of 2024, Maze Cord Blood has ceased accepting new enrollments and redirects prospective customers to its partner MiracleCord, while continuing to store and service all previously collected units. The company is founder-owned and led, with no disclosed institutional capital, and operates with a small staff (11–50 employees). The commercial implication is that the asset is operating in a managed run-off posture, with revenue bounded to the existing installed base.
Maze Cord Blood firmographics
Firmographics- Name
- Maze Cord Blood
- Legal name
- Maze Cord Blood Laboratories
- Website
- https://mazecordblood.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Maze Cord Blood is a private US cord blood and tissue banking service that stores newborn stem cells for expectant-parent families. A subsidiary of Maze Health, it is no longer accepting new enrollments and now operates as a managed run-off, servicing its existing storage book.
- Ownership category
- akta.pro rank
Maze Cord Blood industry classification
Industry- Product category
- Cord Blood Banking
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
- akta.pro secondary industry
- Cell & Gene Therapy Chain-of-Identity/Chain-of-Custody Logistics (HLAGAMAE)
Keywords
Where Maze Cord Blood is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Maze Cord Blood business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Cord Blood Banking Storage: Annual subscription-based storage fees for cord blood and cord tissue units. Customers pay processing fees upfront and annual storage fees for continued preservation of their biological samples.
- Cord Tissue Banking Storage: Annual subscription-based storage fees for umbilical cord tissue containing mesenchymal stem cells (MSCs). Stored separately from cord blood for potential future regenerative medicine applications.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Maze Cord Blood product offering
Product offeringCore offering
Maze Cord Blood collects, processes, and cryogenically stores umbilical cord blood and umbilical cord tissue from newborns for private family use. Customers pay an upfront processing fee and recurring annual storage fees to preserve hematopoietic stem cells from cord blood and mesenchymal stem cells (MSCs) from cord tissue for potential future treatment of blood disorders, cancers, immune deficiencies, metabolic disorders, and regenerative medicine applications. The company is no longer accepting new enrollments and refers prospective customers to partner MiracleCord, while continuing to store all previously collected units.
Product overview
Maze Cord Blood operates as a private cord blood and tissue banking service. The company offers two core storage services: Cord Blood Banking (storage of hematopoietic stem cells from umbilical cord blood) and Cord Tissue Banking (storage of mesenchymal stem cells from umbilical cord tissue). A key proprietary feature is the TissueQES processing method, which provides quantitative evaluation of stem cell survival via post-thaw growth verification. The company is no longer accepting new enrollments but continues to store previously collected units.
Differentiator
Problem solved
Functional benefit
Products and services
- Cord Blood Banking Private cord blood banking service that collects, processes, and cryogenically stores umbilical cord blood rich in hematopoietic stem cells for a family's potential future medical use, including treatment of over 80 blood and immune disorders and cancers.
- Cord Tissue Banking Private cord tissue banking service that collects and stores umbilical cord tissue rich in mesenchymal stem cells (MSCs) for potential future regenerative therapies, including orthopedic and cardiac applications, stored separately from cord blood.
Companies that use Maze Cord Blood
Customer profileNamed customers7 records
Segments1 record
Ideal customer profiles1 record
Maze Cord Blood technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Maze Cord Blood partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- MiracleCordcoreReferral partnership where Maze Cord Blood directs new enrollment inquiries to MiracleCord. The companies have an established relationship for cord blood banking services. Maze continues to store all previously collected cord blood units while MiracleCord handles new customer enrollments. Customers can call MiracleCord at 888-435-5550 or visit MiracleCord.com.
Recent moves4 records
Expansion highlights3 records
Maze Cord Blood competitors and assessment
Company assessmentDirect peers
- StemCyte: Hybrid private and public cord blood bank operating cord blood banking, processing, and therapeutic applications. Comparable in laboratory accreditation profile and core service offering, though with a stronger hybrid public-bank component.
- Cryo-Cell International: Public company (CYCC) operating one of the longest-standing private cord blood and tissue banking services. Directly comparable service offering, customer base, and subscription revenue model, but with greater scale and public-market capital access.
- Americord Registry: Private cord blood and tissue bank offering family banking services including cord blood, cord tissue, and placenta-derived stem cells. Competes with Maze on affordability and product breadth for expectant-parent customers.
- FamilyCord: Private family cord blood bank offering cord blood and cord tissue banking with comparable accreditation (AABB, CLIA). Targets the same expectant-parent buyer with a similar value proposition around affordability and quality.
- MiracleCord: Direct-to-consumer cord blood and tissue bank explicitly named as Maze's referral partner for new enrollments. Operates the same business model (private family banking, AABB-accredited processing) and serves the same expectant-parent segment in the US market.
- LifebankUSA: Private cord blood and tissue bank (a Celularity company) offering family banking services. Comparable product set (cord blood, cord tissue, placental stem cells) and US customer segment to Maze.
- CorCell: Private cord blood and tissue banking service focused on family banking with a comparable product set (cord blood, cord tissue) and similar subscription storage model. Competes for the same expectant-parent customers.
Regional players
- New York Blood Center: Large nonprofit blood banking organization headquartered in New York with public cord blood banking operations through the National Cord Blood Program. Operates a related but public-banked model in Maze's home geography, offering an alternative to family banking.
Broad incumbents
- ViaCord: Established private cord blood bank owned by Revvity (formerly PerkinElmer). Offers cord blood and cord tissue banking with similar accreditation profile to Maze and competes for the same affluent, health-conscious expectant-parent segment.
- CBR (Cord Blood Registry): One of the largest US private cord blood banks, historically part of CBR Systems and now part of CooperCompanies. Competes head-to-head with Maze for expectant-parent customers and has substantially greater scale, marketing budget, and brand recognition.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Maze Cord Blood social profiles
Digital presenceMaze Cord Blood financial estimates
Financial estimateRevenue estimate
Valuation estimate
Maze Cord Blood leadership team
Management profileNumber of profiles
Profiles1 record
Maze Cord Blood funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Maze Cord Blood M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Maze Cord Blood
What does Maze Cord Blood do?
Maze Cord Blood collects, processes, and cryogenically stores umbilical cord blood and umbilical cord tissue from newborns for private family use. Customers pay an upfront processing fee and recurring annual storage fees to preserve hematopoietic stem cells from cord blood and mesenchymal stem cells (MSCs) from cord tissue for potential future treatment of blood disorders, cancers, immune deficiencies, metabolic disorders, and regenerative medicine applications. The company is no longer accepting new enrollments and refers prospective customers to partner MiracleCord, while continuing to store all previously collected units.
Is Maze Cord Blood a public or private company?
Maze Cord Blood is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Maze Cord Blood founded?
Maze Cord Blood was founded in -1. It employs 11 to 50 people.
Where is Maze Cord Blood based?
Maze Cord Blood is headquartered in New York, United States, in the North America region.
How does Maze Cord Blood make money?
Two revenue lines are on record. Cord Blood Banking Storage is the primary driver. The others are cord Tissue Banking Storage.
Who are Maze Cord Blood's main competitors?
Direct peers on record are StemCyte, Cryo-Cell International, Americord Registry, FamilyCord, MiracleCord, LifebankUSA and CorCell. New York Blood Center is listed as a regional player. Broad incumbents are ViaCord and CBR (Cord Blood Registry).
Does Maze Cord Blood have an API?
No public API is recorded for Maze Cord Blood.
What industry is Maze Cord Blood in?
Maze Cord Blood's product category is Cord Blood Banking. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAGAMAE, Cell & Gene Therapy Chain-of-Identity/Chain-of-Custody Logistics. Its NAICS code is 621991 and its SIC code is 8071.